International Research Grants in Congenital Muscular Dystrophy

Cure CMD's International Research Grants in Congenital Muscular Dystrophy sits under Cure CMD, a foundation focused on congenital muscular dystrophy research. The program runs an international request for applications for academic teams working on the disorder's named subtypes, and the most recent cycle in 2022 carried a $400,000 pool. Cycles have run roughly every two to three years since 2008. Awards have reached up to $100,000 for multi-subtype proposals, with most single-subtype projects typically landing around $50,000 to $100,000. Funding is direct-costs only, runs for up to 24 months, and is disbursed in semi-annual allocations. Applicants must be affiliated with accredited academic institutions in good standing, and the competition explicitly welcomes international investigators and junior researchers. Submissions go through ProposalCentral. The foundation limits the science to COL6, LAMA2, dystroglycanopathies, congenital laminopathy, and SELENON-RM, so fit depends on a clear match to one of those disease areas. Proposals are peer reviewed by Cure CMD's Scientific Advisory Board, and the strongest submissions pair subtype-specific biology with a credible path toward treatment or care improvement.

No upcoming rounds verified. Cadence: Triennial.